151 related articles for article (PubMed ID: 33464545)
1. Effect of Food on the Pharmacokinetics of the Oral Docetaxel Tablet Formulation ModraDoc006 Combined with Ritonavir (ModraDoc006/r) in Patients with Advanced Solid Tumours.
Vermunt MAC; de Weger VA; Janssen JM; Lopez-Yurda MI; Keessen M; Thijssen B; Rosing H; Huitema ADR; Beijnen JH; Marchetti S
Drugs R D; 2021 Mar; 21(1):103-111. PubMed ID: 33464545
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of docetaxel and ritonavir after oral administration of ModraDoc006/r in patients with prostate cancer versus patients with other advanced solid tumours.
Vermunt MAC; van der Heijden LT; Hendrikx JJMA; Schinkel AH; de Weger VA; van der Putten E; van Triest B; Bergman AM; Beijnen JH
Cancer Chemother Pharmacol; 2021 Jun; 87(6):855-869. PubMed ID: 33744986
[TBL] [Abstract][Full Text] [Related]
3. A dose-escalation study of bi-daily once weekly oral docetaxel either as ModraDoc001 or ModraDoc006 combined with ritonavir.
de Weger VA; Stuurman FE; Hendrikx JJMA; Moes JJ; Sawicki E; Huitema ADR; Nuijen B; Thijssen B; Rosing H; Keessen M; Mergui-Roelvink M; Beijnen JH; Schellens JHM; Marchetti S
Eur J Cancer; 2017 Nov; 86():217-225. PubMed ID: 29031170
[TBL] [Abstract][Full Text] [Related]
4. ModraDoc006, an oral docetaxel formulation in combination with ritonavir (ModraDoc006/r), in metastatic castration-resistant prostate cancer patients: A phase Ib study.
Vermunt MAC; Robbrecht DGJ; Devriese LA; Janssen JM; Thijssen B; Keessen M; van Eijk M; Kessels R; Eskens FALM; Beijnen JH; Mehra N; Bergman AM
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1367. PubMed ID: 33709626
[TBL] [Abstract][Full Text] [Related]
5. A Phase I Dose Escalation Study of Once-Weekly Oral Administration of Docetaxel as ModraDoc001 Capsule or ModraDoc006 Tablet in Combination with Ritonavir.
de Weger VA; Stuurman FE; Koolen SLW; Moes JJ; Hendrikx JJMA; Sawicki E; Thijssen B; Keessen M; Rosing H; Mergui-Roelvink M; Huitema ADR; Nuijen B; Beijnen JH; Schellens JHM; Marchetti S
Clin Cancer Res; 2019 Sep; 25(18):5466-5474. PubMed ID: 31217201
[TBL] [Abstract][Full Text] [Related]
6. A Population Pharmacokinetic Model of Oral Docetaxel Coadministered With Ritonavir to Support Early Clinical Development.
Yu H; Janssen JM; Sawicki E; van Hasselt JGC; de Weger VA; Nuijen B; Schellens JHM; Beijnen JH; Huitema ADR
J Clin Pharmacol; 2020 Mar; 60(3):340-350. PubMed ID: 31595980
[TBL] [Abstract][Full Text] [Related]
7. Saquinavir 500 mg film-coated tablets demonstrate bioequivalence to saquinavir 200 mg hard capsules when boosted with twice-daily ritonavir in healthy volunteers.
Bittner B; Riek M; Holmes B; Grange S
Antivir Ther; 2005; 10(7):803-10. PubMed ID: 16312177
[TBL] [Abstract][Full Text] [Related]
8. Randomized, Open-Label, Crossover Studies Evaluating the Effect of Food and Liquid Formulation on the Pharmacokinetics of the Novel Focal Adhesion Kinase (FAK) Inhibitor BI 853520.
Verheijen RB; van der Biessen DAJ; Hotte SJ; Siu LL; Spreafico A; de Jonge MJA; Pronk LC; De Vos FYFL; Schnell D; Hirte HW; Steeghs N; Lolkema MP
Target Oncol; 2019 Feb; 14(1):67-74. PubMed ID: 30742245
[TBL] [Abstract][Full Text] [Related]
9. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
10. Effects of posaconazole (a strong CYP3A4 inhibitor), two new tablet formulations, and food on the pharmacokinetics of idasanutlin, an MDM2 antagonist, in patients with advanced solid tumors.
Nemunaitis J; Young A; Ejadi S; Miller W; Chen LC; Nichols G; Blotner S; Vazvaei F; Zhi J; Razak A
Cancer Chemother Pharmacol; 2018 Mar; 81(3):529-537. PubMed ID: 29368050
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial in healthy subjects to assess the bioequivalence of an atazanavir/cobicistat fixed-dose combination tablet versus administration as separate agents.
Sevinsky H; Tao X; Wang R; Ravindran P; Sims K; Xu X; Jariwala N; Bertz R
Antivir Ther; 2015; 20(5):493-500. PubMed ID: 25361436
[TBL] [Abstract][Full Text] [Related]
12. Effect of Food on the Pharmacokinetics and Safety of a Novel c-Met Inhibitor SCC244: A Randomized Phase I Study in Healthy Subjects.
Wu J; Xu H; Li H; Ma L; Chen J; Yuan F; Sheng L; Liu C; Chen W; Li X
Drug Des Devel Ther; 2023; 17():761-769. PubMed ID: 36925997
[TBL] [Abstract][Full Text] [Related]
13. Single-dose pharmacokinetics of 2 or 3 tablets of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen (MNK-155) under fed and fasted conditions: two randomized open-label trials.
Devarakonda K; Kostenbader K; Giuliani MJ; Young JL
BMC Pharmacol Toxicol; 2015 Nov; 16():31. PubMed ID: 26614499
[TBL] [Abstract][Full Text] [Related]
14. Effect of food on the pharmacokinetics of the WEE1 inhibitor adavosertib (AZD1775) in patients with advanced solid tumors.
Någård M; Ah-See ML; So K; Vermunt M; Thistlethwaite F; Labots M; Roxburgh P; Ravaud A; Campone M; Valkenburg-van Iersel L; Ottesen L; Li Y; Mugundu G
Cancer Chemother Pharmacol; 2020 Jul; 86(1):97-108. PubMed ID: 32556602
[TBL] [Abstract][Full Text] [Related]
15. Effects of food intake on the pharmacokinetic properties of mirabegron oral controlled-absorption system: a single-dose, randomized, crossover study in healthy adults.
Lee J; Zhang W; Moy S; Kowalski D; Kerbusch V; van Gelderen M; Sawamoto T; Grunenberg N; Keirns J
Clin Ther; 2013 Mar; 35(3):333-41. PubMed ID: 23497763
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of a novel orodispersible tablet of sildenafil in healthy subjects.
Damle B; Duczynski G; Jeffers BW; Crownover P; Coupe A; LaBadie RR
Clin Ther; 2014 Feb; 36(2):236-44. PubMed ID: 24447534
[TBL] [Abstract][Full Text] [Related]
17. No relation between docetaxel administration route and high-grade diarrhea incidence.
Hendrikx JJMA; Stuurman FE; Song JY; de Weger VA; Lagas JS; Rosing H; Beijnen JH; Schinkel AH; Schellens JHM; Marchetti S
Pharmacol Res Perspect; 2020 Aug; 8(4):e00633. PubMed ID: 32725720
[TBL] [Abstract][Full Text] [Related]
18. Effect of Food on the Pharmacokinetics of Tenofovir Amibufenamide: A Phase I, Randomized, Open-Label, Two-Period Crossover Trial in Healthy Adult Subjects.
Liu J; Wu M; Kai J; Lin M; Zheng Y; Jiang Y; Huang Q; Zhai Y; Qiu Y
Drug Des Devel Ther; 2023; 17():3061-3072. PubMed ID: 37840641
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the effects of formulation, food, or a proton-pump inhibitor on the pharmacokinetics of glasdegib (PF-04449913) in healthy volunteers: a randomized phase I study.
Shaik N; Hee B; Wei H; LaBadie RR
Cancer Chemother Pharmacol; 2019 Mar; 83(3):463-472. PubMed ID: 30536154
[TBL] [Abstract][Full Text] [Related]
20. Quantification of the pharmacokinetic-toxicodynamic relationship of oral docetaxel co-administered with ritonavir.
Yu H; Janssen JM; de Weger VA; Nuijen B; Stuurman RE; Marchetti S; Schellens JHM; Beijnen JH; Dorlo TPC; Huitema ADR
Invest New Drugs; 2020 Oct; 38(5):1526-1532. PubMed ID: 32306204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
